Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson’s Disease Penetrance

San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Riboldazzi G, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R and the Michael J Fox Foundation LRRK2 Cohort Consortium
Mov Disord. 2020 Oct;35(10):1755-1764. doi: 10.1002/mds.28189. Epub 2020 Jul 14.
https://pubmed.ncbi.nlm.nih.gov/32662532/

Scroll to Top